
Medtronic receives FDA approval for renal denervation device
The company received approval for the hypertension treatment despite a mixed vote from an FDA advisory panel.

The company received approval for the hypertension treatment despite a mixed vote from an FDA advisory panel.

Jeff Shuren, director of the Center for Devices and Radiological Health, said the test will give patients “more information about their health from the privacy of
their own home.”

Lehi, Utah-based Owlet designed the system to enable caregivers to better care for babies at home through advanced digital technologies.

Recor Medical announced that the FDA approved its Paradise ultrasound renal denervation (RDN) system for treating hypertension.

Interventional Systems announced that the FDA granted a new 510(k) clearance for its Micromate surgical robot system.

DePuy Synthes, the orthopedic device business of Johnson & Johnson (NYSE: JNJ)+
, has won FDA 510(k) clearance for its TriLeap lower extremity anatomic plating system.

Medtronic (NYSE:MDT) announced that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system

ZKR Orthopedics, Inc., a clinical stage medical device company, today announced that its LIFT implant technology has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

The money also will help fund clinical trials for additional indications and the expansion of its manufacturing capabilities.

The startup affiliated with Johns Hopkins University said it is opening a bridge round for its series B financing as it targets more applications for the robotic surgery assistant.